Tonix Pharmaceuticals Hol...

NASDAQ: TNXP · Real-Time Price · USD
51.66
-7.92 (-13.29%)
At close: Aug 15, 2025, 1:03 PM

Tonix Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.57 -20.25 -204.71 -17.49K
PEG Ratio
0.01 -0.03 3.99 260.83
PS Ratio
7.40 304.09 2.65K n/a
PB Ratio
0.53 22.38 115.48 7.38K
P/FCF Ratio
-1.22 -21.49 -163.65 -14.56K
P/OCF Ratio
-1.23 -23.16 -244.01 -21.36K
OCF/S Ratio
-6.04 -13.13 -10.86 n/a
Debt / Equity Ratio
0.06 0.09 0.00 0.00
Quick Ratio
6.04 1.78 7.64 9.06
Current Ratio
6.50 2.53 7.19 8.71
Asset Turnover
0.06 0.05 0.04 n/a
Interest Coverage
n/a n/a -521.18 n/a
Return on Equity
-0.93 -1.11 -0.56 -0.42
Return on Assets
-0.8 -0.76 -0.52 -0.38
Return on Invested Capital
-0.92 -0.86 -0.57 -0.42
Dividend Yield
n/a n/a 0.00 n/a
Payout Ratio
n/a n/a -0.06 n/a
Gross Profit Margin
0.23 0.39 0.89 n/a
Net Profit Margin
-12.88 -15.02 -12.95 n/a
Pretax Profit Margin
-12.88 -15.02 -12.21 n/a
Operating Profit Margin
-13.54 -15.24 -12.41 n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-12.54 -14.69 -12.28 n/a